Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700 Buy
+10
New +$517 ﹤0.01% 858
2025
Q4
Sell
-100
Closed -$2.58K 954
2025
Q3
$2.58K Hold
100
﹤0.01% 782
2025
Q2
$2.76K Buy
+100
New +$2.63K ﹤0.01% 776

Other funds holding MRNA

D.J. St. Germain's MRNA Position: Q2 2026 in Review

D.J. St. Germain opened a new position in Moderna (MRNA) in Q2 2026: 10 shares worth $700. The stake represents ﹤0.01% of the portfolio and ranks #858 among its holdings. This is a return to the name: D.J. St. Germain previously reported a position in MRNA as recently as Q3 2025.

D.J. St. Germain first reported a position in MRNA in Q2 2025 and has held it in 3 quarters since. The position peaked at $2.76K in Q2 2025. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • D.J. St. Germain held 10 shares of Moderna worth $700 as of Q2 2026.
  • Moderna was a new D.J. St. Germain position in Q2 2026.
  • Moderna made up ﹤0.01% of D.J. St. Germain's portfolio in Q2 2026, its #858 holding.
  • D.J. St. Germain first reported a position in Moderna in Q2 2025 and has held it in 3 quarters since.
  • D.J. St. Germain's Moderna position peaked at $2.76K in Q2 2025.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.